Effect of desipramine, fluoxetine and tranylcypromine on viability and apoptosis of rat primary neuronal and astrocytic cell cultures subjected to oxygen-glucose deprivation in vitro
Anna Pudelko
Pharmacological Reports, 2015
View PDFchevron_right
Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region
Andrzej Pilc
European Journal of Pharmacology, 1998
View PDFchevron_right
Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus
Andrea Caricasole
Neuropharmacology, 2002
View PDFchevron_right
Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex
Andrzej Pilc
Brain Research, 2007
View PDFchevron_right
Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of β-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands
Daniela Melchiorri
Journal of Neurochemistry, 2005
View PDFchevron_right
Comparative Effects of LY3020371, a Potent and Selective mGlu2/3 Receptor Antagonist, and Ketamine, a Non-Competitive NMDA Receptor Antagonist, in Rodents: Evidence Supporting Use for the Treatment of Depression
Jeffrey Witkin
The Journal of pharmacology and experimental therapeutics, 2017
View PDFchevron_right
mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants
Yukio Ago
Neuropharmacology, 2013
View PDFchevron_right
Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression
Craig Stockmeier, Jose J A V I E R Miguel-Hidalgo
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010
View PDFchevron_right
Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity
Piotr Brański
Pharmacological reports : PR
View PDFchevron_right
On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039
Andrzej Pilc
Psychopharmacology, 2010
View PDFchevron_right
Is the mGlu5 receptor a possible target for new antidepressant drugs?
Andrzej Pilc
Pharmacological Reports, 2013
View PDFchevron_right
Increase in neurogenesis and behavioural benefit after chronic fluoxetine treatment in Wistar rats
Anders Klein
Acta Neurologica Scandinavica, 2007
View PDFchevron_right
GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine
Dalma Kurko
Neurochemistry International, 2012
View PDFchevron_right
Modulation of glutamate receptors: Strategies for the development of novel antidepressants
Phil Skolnick
Amino Acids, 2002
View PDFchevron_right
The Action of Antidepressants on the Glutamate System: Regulation of Glutamate Release and Glutamate Receptors
Laura Musazzi
Biological Psychiatry, 2013
View PDFchevron_right
On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants
Andrzej Pilc
Polish journal of pharmacology
View PDFchevron_right
Group III metabotropic glutamate receptor-mediated, chemically induced long-term depression differentially affects cell viability in the hippocampus
Denise Manahan-Vaughan
European Journal of Pharmacology, 2006
View PDFchevron_right
Antidepressant fluoxetine suppresses neuronal growth from both vertebrate and invertebrate neurons and perturbs synapse formation between Lymnaea neurons
Fenglian Xu, Wali Zaidi, Naweed Syed
European Journal of Neuroscience, 2010
View PDFchevron_right
In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders
James Monn
Psychopharmacology, 2007
View PDFchevron_right
Neurogenesis-Dependent and Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression
bruno guiard
Neuron, 2009
View PDFchevron_right
A characterisation of long-term depression induced by metabotropic glutamate receptor activation in the rat hippocampus in vitro
Graham Collingridge
The Journal of Physiology, 2001
View PDFchevron_right
Pharmacological Activation of mGlu4 Metabotropic Glutamate Receptors Reduces Nigrostriatal Degeneration in Mice Treated with 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine
Valeria Flowhara Bruno
The Journal of Neuroscience, 2006
View PDFchevron_right
Glutamate-Based Antidepressants: Preclinical Psychopharmacology
Phil Skolnick, Andrzej Pilc
Biological Psychiatry, 2013
View PDFchevron_right
Antidepressant action: to the nucleus and beyond
Jessica Malberg
Trends in Pharmacological Sciences, 2005
View PDFchevron_right
Behavioral Effects of Fluoxetine in an Animal Model of Anxiety/Depression Are Mediated by Both Neurogenesis-Dependent and Independent Mechanisms
bruno guiard
View PDFchevron_right
Activation of the mGlu7 receptor elicits antidepressant-like effects in mice
Herman Van Der Putten, Andrzej Pilc
Psychopharmacology, 2007
View PDFchevron_right
Prolonged administration of antidepressant drugs leads to increased binding of [3H]MPEP to mGlu5 receptors
Andrzej Pilc
Neuropharmacology, 2014
View PDFchevron_right
Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not mGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the mGlu2/3 Receptor Agonist (-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)
Kjell Svensson
Journal of Pharmacology and Experimental Therapeutics, 2008
View PDFchevron_right